Monoclonal antibody therapies against SARS-CoV-2

Monoclonal antibodies (mAbs) targeting the spike protein of SARS-CoV-2 have been widely used in the ongoing COVID-19 pandemic. In this paper, we review the properties of mAbs and their effect as therapeutics in the pandemic, including structural classification, outcomes in clinical trials that led t...

Descripción completa

Detalles Bibliográficos
Autores principales: Focosi, Daniele, McConnell, Scott, Casadevall, Arturo, Cappello, Emiliano, Valdiserra, Giulia, Tuccori, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255948/
https://www.ncbi.nlm.nih.gov/pubmed/35803289
http://dx.doi.org/10.1016/S1473-3099(22)00311-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255948/
https://www.ncbi.nlm.nih.gov/pubmed/35803289
http://dx.doi.org/10.1016/S1473-3099(22)00311-5

Ejemplares similares